[1]
G. Aktas, “A Scoping Review on Recent Advances in Antidiabetic Medications: From GLP-1 Receptor Agonists to Dual and Triple Agonists”, ADV CLIN PHARMACOL THER, vol. 2, no. 2, pp. 47–57, Sep. 2025, doi: 10.63623/8cv4gh26.